Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
Clinical trial NCT04845178 · COMPLETED
Trial details
- NCT number
- NCT04845178
- Sponsor
- AEON Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2024-06-19
- Enrollment
- 797
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.